dipyridamole has been researched along with Hypertrophy, Right Ventricular in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hypertrophy, Right Ventricular: Enlargement of the RIGHT VENTRICLE of the heart. This increase in ventricular mass is often attributed to PULMONARY HYPERTENSION and is a contributor to cardiovascular morbidity and mortality.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schulman, DS | 1 |
| Lazar, JM | 1 |
| Ziady, G | 1 |
| Grandis, DJ | 1 |
| Flores, AR | 1 |
| Orie, JE | 1 |
1 other study available for dipyridamole and Hypertrophy, Right Ventricular
| Article | Year |
|---|---|
Right ventricular thallium-201 kinetics in pulmonary hypertension: relation to right ventricular size and function.
Topics: Adult; Dipyridamole; Female; Heart; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; | 1993 |